Bloomberg: Balance of Power focuses on the politics and policies being shaped by the agenda of President Biden’s administration.
Bloomberg: Balance of Power focuses on the politics and policies being shaped by the agenda of President Biden’s administration.
Nissan Motor Co.’s former top lawyer, who led an internal investigation into alleged financial misconduct by Carlos Ghosn, said he endured retaliation, demotions and even surveillance of his family after questioning the integrity of the probe.
US Corporations Are Still Lining Up to Buy Back Their Own Shares
Biotechs CinCor, Albireo Jump on Takeovers by Larger Drugmakers
US Inflation May Not Be So Bad, Pre-World War II Data Suggest
US Consumers’ Inflation Expectations Slip in New York Fed Survey
BOE Chief Economist Signals UK Inflationary Pressures May Be Easing
Tesla’s New No. 2 Won Musk Over by Working Around the Clock
New This Week: Margo Price And ‘Gold, Lies & Videotape’
Tencent-Backed WeDoctor Plans IPO Filing by End of April
iPhone Exports from India Double to Surpass $2.5 Billion
Earnings Remain Key Risk for Tech Stocks After Worst Year Since 2008
Trump Deposition in Rape Accuser’s Lawsuit Ordered Unsealed
Brazil Football Condemns Rioters Storming Capital in Iconic Jersey
Ex-Banker Eyes M&A After SPAC Deal Forges $60 Billion Wealth Firm
Citadel Plots Out NYC Tower in Major Buildout After Banner Year
Kingsbury, Keim Out as Cardinals Undergo Franchise Makeover
Rolls-Royce Says Super Rich Keep on Buying Luxury Cars
Social Media Firms Failed Once Again in Brazil
Noma and the Search for a Second Act
China’s Messy Reopening Takes the Edge Off Dash for Gas
Who Owns the Content AI Creates?
America’s Aggressive Chip Strategy Forces China Into a Corner
Silicon Valley Can’t Quit Its Pizza Robot Obsession
Gender Pay Equity Progress in US Is Slowed by Family Leave, Study Says
GOP-Led States Rejected by Supreme Court on Immigrant Wealth Tests
Earth’s Ozone Layer Is Recovering as Damaging Chemicals Phased Out
Ford to Partner With LG on Turkey Battery Plant, Drops SK
Vancouver Skyscraper Twists Around Zoning Restrictions
NYC Subway Crime Jumps 30%, Defying Surge in Police Patrols
Extreme Acceleration Is the New Traffic Safety Frontier
Solana Is Trying to Break Its Ties With Bankrupt FTX (Podcast)
Ex-FTX US President Harrison to ‘Share in Time’ What He Knew About Firm
Hong Kong Stresses Pro-Crypto Stance as Industry Reels
Doctors are prescribing the drug off label to people for weight loss
Photographer: Getty Images
Emma Court
Subscriber Benefit
Subscribe
Sign In
For more than a month, Shane Anthony, a 57-year-old auto mechanic, hasn’t been able to get his diabetes medication.
Ozempic, an injection that keeps blood sugar levels in check for patients with type 2 diabetes, has been in shortage for about four months, according to the database maintained by the US Food and Drug Administration, and is backordered at Anthony’s Seattle pharmacy. Without the Novo Nordisk A/S-made prescription, he has suffered recurring dizzy spells while repairing cars. Alternative medications are either out of stock or not covered by his insurance.
